Concepedia

Marita Kloess

MK

8

Publications

1K

Citations

8

H-Index

2003

Active since

Affiliations

Saarland University(Current)

Asklepios Klinik St. Georg

Leipzig University

University of Cologne

Christian-Albrechts-Universität zu Kiel

Marita Kloess is an author at Saarland University specializing in neurology, neuro-oncology, and neuropathology.

Top concepts

Publications per year

2003–2008

8

Publications

8

NAD(P)H Oxidase and Multidrug Resistance Protein Genetic Polymorphisms Are Associated With Doxorubicin-Induced Cardiotoxicity

Leszek Wojnowski, Bettina Kulle, Markus Schirmer et al. · Circulation · 2005 · 481 citations

Incidence and risk factors of central nervous system recurrence in aggressive lymphoma—a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)

Volkmar Boehme, Samira Zeynalova, Marita Kloess et al. · Annals of Oncology · 2006 · 274 citations · Full text

, , +6

Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin’s lymphoma: results from the NHL-B trial of the GermanHigh-Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL)

A. Wunderlich, Marita Kloess, Marcel Reiser et al. · Annals of Oncology · 2003 · 98 citations

Six, Not Eight Cycles of Bi-Weekly CHOP with Rituximab (R-CHOP-14) Is the Preferred Treatment for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Michael Pfreundschuh, Marita Kloess, Rudolf Schmits et al. · Blood · 2005 · 56 citations

Four versus six courses of a dose‐escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation

Nobert Schmitz, Marita Kloess, Marcel Reiser et al. · Cancer · 2005 · 37 citations · Full text

Rows per page

1–5 of 8